Table 2

Procedural variables

CharacteristicsIA thrombolytics (n=95)No IA thrombolytics (n=2168)P value
Thrombectomy technique, n (%)*
 Stent retriever61/95 (64.2)1647/2168 (76.0)0.01
 Aspiration21/95 (22.1)884/2168 (40.8)<0.001
 Other9/95 (9.5)141/2168 (6.5)0.26
Total revascularisation attempts, n (%)
 119/67 (28.4)803/1994 (40.3)0.09
 224/67 (35.8)470/1994 (23.6)
 310/67 (14.9)316/1994 (15.8)
 ≥414/67 (20.9)405/1994 (20.3)
IA thrombolytics, n (%)
 Urokinase†63/95 (66.3)N/A
 Alteplase‡32/95 (33.7)N/A
IA thrombolytics attempt, n (%)
 Primary attempt26/91 (28.6)N/A
 Adjuvant attempt65/91 (71.4)N/A
Location occlusion IA thrombolytics, n (%)
 Proximal occlusion67/88 (76.1)N/A
 Distal occlusion21/88 (23.9)N/A
General anaesthesia, n (%)32/90 (35.6)562/2091 (26.9)0.07
Time from stroke onset to groin puncture, median (IQR), minutes200 (154–250)190 (150–245)0.37
Time from groin puncture to recanalisation or last contrast bolus, median (IQR), minutes72 (58–108)60 (40–85)<0.001
  • *Sum may be less than 100% due to administration of IA thrombolytics only, or exceed 100% due to a combination of treatment techniques.

  • †Median dose was 250 000 IU (IQR, 1 93 750–2 50 000).

  • ‡Median dose was 20 mg (IQR, 12–20).

  • IA, intra-arterial; n, number; N/A, not applicable.